Drug Approval | November 21, 2025
FDA grants accelerated approval to sevabertinib for non-squamous non-small cell lung cancer
HER2-mutant NSCLC typically has a poor prognosis and limited treatment options
HER2-mutant NSCLC typically has a poor prognosis and limited treatment options
The formulation is backed by over 80 clinical trials and 200 scientific publications
The move is expected to be crucial during health crises
This move positions the U.S.-based consumer healthcare company for a significantly larger role in the rapidly expanding at-home and retail diagnostic testing market
Comirnaty, Pfizer’s COVID-19 prevention vaccine, reported global sales of $1.15 billion
VLA1601 is a purified and inactivated vaccine specifically designed to protect against the Zika virus
Capvaxive has recorded $530 million in cumulative sales over its first four quarters on the market
Quest Diagnostics’ blood-based test panels demonstrate confirmatory accuracy, potentially reducing the need for PET imaging
Indegene is strengthening its Consulting Practice to help life sciences organizations address their most pressing challenges with speed, impact, and accountability
Medroxyprogesterone acetate-SC is a three-month contraceptive that can be administered by healthcare workers or self-injected after appropriate training
Subscribe To Our Newsletter & Stay Updated
